Drugs / BU
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05814731 Background | Apr 2023 → Dec 2025 | disease related to hematopoietic stem cell transplant | First Affiliated Hospital Xi'an Jiaotong University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BU | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05814731 ↗ |
| Route | Intravenous | “BU 0.8 mg/kg q6h，ivgtt，d-8- -6” NCT05814731 ↗ |